IQVIA (IQV) TRADE BRIEF

SETUP

IQV broke above $273.93 on 1.64x average volume, closing near session highs at $275.52 after gapping up 2.84% from $267.49. The candle structure shows buyers in control with a tight low-to-close range and price pressing against the 52-week high of $277.40. A clean break above $277.40 would put IQV in blue sky territory with limited overhead resistance. The signal quality score of 50/100 is a caution flag — price is entering extended territory near a key ceiling, not early in the move.

CATALYSTS

IQV has beaten EPS estimates in five consecutive quarters, demonstrating consistent execution. The most recent beat of 2.6% on May 6 shows operational resilience. The CRO and data analytics sector benefits from ongoing pharma outsourcing trends and AI-driven clinical trial optimization. Heavy insider buying is notable — CEO Bousbib purchased over 262,000 shares across two transactions in late July, totaling nearly $38M. That is a strong conviction signal from the person with the most visibility into the business.

RISKS

Price is sitting just $1.88 below the 52-week high. A rejection here creates a double-top technical pattern that could reverse quickly. Stop at $267.09 is roughly 3% below current price, which is manageable, but the R/R of 1:1.62 is modest given the proximity to resistance. Signal quality at 50/100 confirms this is not a clean early-entry setup. No recent news headlines means the catalyst driving today's gap is unclear — unexplained moves can reverse. Next earnings are distant, removing a near-term fundamental catalyst to sustain momentum.

CONVICTION: Medium

Massive CEO buying and consistent earnings beats support the bull case, but entry near the 52-week high with a below-average signal quality score limits confidence in follow-through.

Entry: Current levels near $275

Stop: $267.09

TP1: $289.19

TP2: $298.31